首页> 美国卫生研究院文献>Molecular and Cellular Biology >HIRA the Human Homologue of Yeast Hir1p and Hir2p Is a Novel Cyclin-cdk2 Substrate Whose Expression Blocks S-Phase Progression
【2h】

HIRA the Human Homologue of Yeast Hir1p and Hir2p Is a Novel Cyclin-cdk2 Substrate Whose Expression Blocks S-Phase Progression

机译:HIRA酵母Hir1p和Hir2p的人类同源物是一种新型的Cyclin-cdk2底物其表达可阻止S期进程。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Substrates of cyclin-cdk2 kinases contain two distinct primary sequence motifs: a cyclin-binding RXL motif and one or more phosphoacceptor sites (consensus S/TPXK/R or S/TP). To identify novel cyclin-cdk2 substrates, we searched the database for proteins containing both of these motifs. One such protein is human HIRA, the homologue of two cell cycle-regulated repressors of histone gene expression in Saccharomyces cerevisiae, Hir1p and Hir2p. Here we demonstrate that human HIRA is an in vivo substrate of a cyclin-cdk2 kinase. First, HIRA bound to and was phosphorylated by cyclin A- and E-cdk2 in vitro in an RXL-dependent manner. Second, HIRA was phosphorylated in vivo on two consensus cyclin-cdk2 phosphoacceptor sites and at least one of these, threonine 555, was phosphorylated by cyclin A-cdk2 in vitro. Third, phosphorylation of HIRA in vivo was blocked by cyclin-cdk2 inhibitor p21cip1. Fourth, HIRA became phosphorylated on threonine 555 in S phase when cyclin-cdk2 kinases are active. Fifth, HIRA was localized preferentially to the nucleus, where active cyclin A- and E-cdk2 are located. Finally, ectopic expression of HIRA in cells caused arrest in S phase and this is consistent with the notion that it is a cyclin-cdk2 substrate that has a role in control of the cell cycle.
机译:细胞周期蛋白-cdk2激酶的底物包含两个不同的一级序列基序:一个细胞周期蛋白结合的RXL基序和一个或多个磷酸受体位点(共识S / TPXK / R或S / TP)。为了鉴定新型的cyclin-cdk2底物,我们在数据库中搜索了包含这两个基序的蛋白质。一种这样的蛋白质是人HIRA,这是酿酒酵母中两个细胞周期调节的组蛋白基因表达阻遏物的同源物,Hir1p和Hir2p。在这里,我们证明了人类HIRA是细胞周期蛋白cdk2激酶的体内底物。首先,HIRA在体外以RXL依赖的方式与细胞周期蛋白A和E-cdk2结合并被其磷酸化。其次,HIRA在体内被两个共有的cyclin-cdk2磷酸受体位点磷酸化,其中至少一个苏氨酸555在体外被cyclin A-cdk2磷酸化。第三,细胞周期蛋白-cdk2抑制剂p21 cip1 阻止了HIRA的磷酸化。第四,当周期蛋白-cdk2激酶活跃时,HIRA在S期在苏氨酸555上被磷酸化。第五,HIRA优先定位于细胞周期中活跃的细胞周期蛋白A-和E-cdk2所在的核。最后,HIRA在细胞中的异位表达导致S期停滞,这与以下观念相符:它是细胞周期蛋白cdk2底物,在细胞周期控制中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号